Human normal immunoglobulin in the treatment of primary immunodeficiency diseases

References

• NotarangeloLDFischerAGehaRSPrimary immunodeficiencies: 2009 updateJ Allergy Clin Immunol200912461161117820004777
   PubMed Web of Science ®Google Scholar
• HermaszewskiRAWebsterADPrimary hypogammaglobulinaemia: a survey of clinical manifestations and complicationsQ J Med199386131428438047
   PubMedGoogle Scholar
• Cunningham-RundlesCBodianCCommon variable immunodeficiency: clinical and immunological features of 248 patientsClin Immunol1999921344810413651
   PubMed Web of Science ®Google Scholar
• KainulainenLVarpulaMLiippoKSvedstromENikoskelainenJRuuskanenOPulmonary abnormalities in patients with primary hypogammaglobulinemiaJ Allergy Clin Immunol199910451031103610550749
   PubMed Web of Science ®Google Scholar
• MichelMChanetVGalicierLAutoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literatureMedicine (Baltimore)200483425426315232313
   PubMed Web of Science ®Google Scholar
• BrutonOCAgammaglobulinemia (congenital absence of gamma globulin); report of a caseMed Ann Dist Columbia1953221264865013110394
   PubMedGoogle Scholar
• ChurchJALeiblHSteinMREfficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiencyJ Clin Immunol200626438839516705486
   PubMed Web of Science ®Google Scholar
• ShahSRA newer immunoglobulin intravenous (IGIV) – Gammagard liquid 10%: evaluation of efficacy, safety, tolerability and impact on patient careExpert Opin Biol Ther20088679980418476791
   PubMed Web of Science ®Google Scholar
• SteinMRNelsonRPChurchJASafety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficienciesJ Clin Immunol200929113714418814020
   PubMed Web of Science ®Google Scholar
• BergerMPinciaroPJAlthausAEfficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiencyJ Clin Immunol201030232132919997861
   PubMed Web of Science ®Google Scholar
• GardulfAHammarstromLSmithCIHome treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusionLancet199133887601621661712881
   PubMed Web of Science ®Google Scholar
• ChapelHBrennanVDelsonEImmunoglobulin replacement therapy by self-infusion at homeClin Exp Immunol19887311601623168330
   PubMed Web of Science ®Google Scholar
• ShapiroRSubcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysisJ Clin Immunol201030230130720082124
   PubMed Web of Science ®Google Scholar
• UK Medical Research CouncilHypogammaglobulinaemia in the United KingdomSpecial Report Series London HMSOLondon, UKUK Medical Research Council1971
   Google Scholar
• LiuZAlbonEHydeCThe effectiveness and cost-effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: a systematic review and economic evaluationWest Midlands Health Technology Assessment Group, Dept of Public Health and Epidemiology, University of Birmingham2006
   Google Scholar
• ChapelHLucasMLeeMCommon variable immunodeficiency disorders: division into distinct clinical phenotypesBlood2008112227728618319398
   PubMed Web of Science ®Google Scholar
• RoifmanCMSchroederHBergerMComparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialInt Immunopharmacol2003391325133312890430
   PubMed Web of Science ®Google Scholar
• AghamohammadiAMoinMFarhoudiAEfficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemiaFEMS Immunol Med Microbiol200440211311814987729
   PubMed Web of Science ®Google Scholar
• BussePJRazviSCunningham-RundlesCEfficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiencyJ Allergy Clin Immunol200210961001100412063531
   PubMed Web of Science ®Google Scholar
• de GraciaJVendrellMAlvarezAImmunoglobulin therapy to control lung damage in patients with common variable immunodeficiencyInt Immunopharmacol20044674575315135316
   PubMed Web of Science ®Google Scholar
• EijkhoutHWvan Der MeerJWKallenbergCGThe effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trialAnn Intern Med2001135316517411487483
   PubMed Web of Science ®Google Scholar
• Cunningham-RundlesCSiegalFPSmithwickEMEfficacy of intravenous immunoglobulin in primary humoral immunodeficiency diseaseAnn Intern Med198410144354396206756
   PubMed Web of Science ®Google Scholar
• PlebaniASoresinaARondelliRClinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter studyClin Immunol2002104322123012217331
   PubMed Web of Science ®Google Scholar
• QuintiISoresinaAGuerraAEffectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort studyJ Clin Immunol201131331532221365217
   PubMed Web of Science ®Google Scholar
• ChapelHMSpickettGPEricsonDEnglWEiblMMBjorkanderJThe comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyJ Clin Immunol20002029410010821460
   PubMed Web of Science ®Google Scholar
• BorteMBernatowskaEOchsHDRoifmanCMEfficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficienciesClin Exp Immunol2011164335736421413943
   PubMed Web of Science ®Google Scholar
• HoffmannFGrimbacherBThielJPeterHHBelohradskyBHHome-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiencyEur J Med Res201015623824520696632
   PubMed Web of Science ®Google Scholar
• BergerMRojavinMKiesslingPZenkerOPharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficienciesClin Immunol2011139213314121353644
   PubMed Web of Science ®Google Scholar
• LucasMLeeMLortanJLopez-GranadosEMisbahSChapelHInfection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 yearsJ Allergy Clin Immunol2010125613541360e135420471071
   PubMed Web of Science ®Google Scholar
• OrangeJSGrossmanWJNavickisRJWilkesMMImpact of trough IgG on pneumonia incidence in primary immunodeficiency: A metaanalysis of clinical studiesClin Immunol20101371213020675197
   PubMed Web of Science ®Google Scholar
• KhanSGrimbacherBBoeckingCSerum trough IgG level and annual intravenous immunoglobulin dose are not related to body size in patients on regular replacement therapyDrug Metab Lett20115213213621457142
   PubMedGoogle Scholar
• YongPLBoyleJBallowMUse of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyClin Immunol2010135225526319914873
   PubMed Web of Science ®Google Scholar
• RoifmanCMBergerMNotarangeloLDManagement of primary antibody deficiency with replacement therapy: summary of guidelinesImmunol Allergy Clin North Am200828487587618940580
   PubMed Web of Science ®Google Scholar
• ShehataNPaldaVBowenTThe use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guidelineTransfus Med Rev201024Suppl 1S285019962579
   PubMed Web of Science ®Google Scholar
• RachidRCastellsMCunningham-RundlesCBonillaFAAssociation of anti-IgA antibodies with adverse reactions to gamma-globulin infusionJ Allergy Clin Immunol20111281228230e22121397310
   PubMed Web of Science ®Google Scholar
• FeldmeyerLBendenCHaileSRNot all intravenous immunoglobulin preparations are equally well toleratedActa Derm Venereol201090549449720814625
   PubMed Web of Science ®Google Scholar
• ChapelHMChristieJMPeachVChapmanRWFive-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis CClin Immunol200199332032411358426
   PubMed Web of Science ®Google Scholar
• QuintiIPierdominiciMMarzialiMEuropean surveillance of immunoglobulin safety – results of initial survey of 1243 patients with primary immunodeficiencies in 16 countriesClin Immunol2002104323123612217332
   PubMed Web of Science ®Google Scholar
• SpickettGPAskewTChapelHMManagement of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseasesQual Health Care19954426326810156396
   PubMedGoogle Scholar
• BloreJHaeneyMRPrimary antibody deficiency and diagnostic delayBr Med J198929866725165172495090
   PubMed Web of Science ®Google Scholar
• SeymourBMilesJHaeneyMPrimary antibody deficiency and diagnostic delayJ Clin Pathol200558554654715858130
   PubMed Web of Science ®Google Scholar
• ChapelHMConsensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody DeficienciesBr Med J199430869285815858148684
   PubMed Web of Science ®Google Scholar
• KainulainenLNikoskelainenJRuuskanenODiagnostic findings in 95 Finnish patients with common variable immunodeficiencyJ Clin Immunol200121214514911332653
   PubMed Web of Science ®Google Scholar
• WangJCunningham-RundlesCTreatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)J Autoimmun2005251576215994061
   PubMed Web of Science ®Google Scholar
• SordetCCantagrelASchaeverbekeTSibiliaJBone and joint disease associated with primary immune deficienciesJoint Bone Spine200572650351416376804
   PubMed Web of Science ®Google Scholar
• WoodPPrimary antibody deficiency syndromesAnn Clin Biochem200946Pt 29910819151170
   PubMed Web of Science ®Google Scholar
• WoodPStanworthSBurtonJRecognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewClin Exp Immunol2007149341042317565605
   PubMed Web of Science ®Google Scholar
• MellemkjaerLHammarstromLAndersenVCancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish studyClin Exp Immunol2002130349550012452841
   PubMed Web of Science ®Google Scholar
• GardulfABjorvellHGustafsonRHammarstromLSmithCIThe life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusionsClin Exp Immunol19939222002047683584
   PubMed Web of Science ®Google Scholar
• BergnerMBobbittRACarterWBGilsonBSThe Sickness Impact Profile: development and final revision of a health status measureMed Care19811987878057278416
   PubMed Web of Science ®Google Scholar
• BergerMMurphyERileyPBergmanGEImproved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin GSouth Med J2010103985686320689467
   PubMed Web of Science ®Google Scholar
• HowardVGreeneJMPahwaSThe health status and quality of life of adults with X-linked agammaglobulinemiaClin Immunol20061182–320120816377251
   PubMed Web of Science ®Google Scholar
• LedermanHMWinkelsteinJAX-linked agammaglobulinemia: an analysis of 96 patientsMedicine (Baltimore)19856431451562581110
   PubMed Web of Science ®Google Scholar
• AghamohammadiAMontazeriAAbolhassaniHHealth-related quality of life in primary antibody deficiencyIran J Allergy Asthma Immunol2011101475121358015
   PubMed Web of Science ®Google Scholar
• TcheurekdjianHPalermoTHostofferRQuality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapyAnn Allergy Asthma Immunol200493216016515328676
   PubMed Web of Science ®Google Scholar
• GalliEBarbieriCCantaniASolanoALonghiMABusincoLTreatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-upAnn Allergy1990642 Pt 11471502106278
   PubMedGoogle Scholar
• GardulfAAndersenVBjorkanderJSubcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsLancet199534589463653697845120
   PubMed Web of Science ®Google Scholar
• HogyBKeineckeHOBorteMPharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insuranceEur J Health Econ200561242915480920
   PubMedGoogle Scholar
• LippertBBergerKBerntorpECost effectiveness of haemophilia treatment: a cross-national assessmentBlood Coagul Fibrinolysis200516747748516175006
   PubMed Web of Science ®Google Scholar